Healthcare

Request for TOC Request for Sample
BUY NOW

Middle East and Africa Chronic Disease Management Market – Industry Trends and Forecast to 2028

Healthcare | Published Report | Jun 2021 | MEA | 350 Pages | No of Tables: 74 | No of Figures: 45

Report Description

Middle East and Africa Chronic Disease Management Market, By Type (Solution and Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer and Others), End User (Healthcare Providers, Healthcare Payers, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast To 2028


Market Analysis and Insights: Middle East and Africa Chronic Disease Management Market

The chronic disease management market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.7% in the forecast period of 2021 to 2028 and is expected to reach USD 591.09 million by 2028. The growing prevalence of chronic diseases is expected to act as a driver for the chronic disease management market.

Chronic disease management (CDM) is ongoing care and support to assist individuals impacted by a chronic health condition with the medical care, knowledge, skills, and resources they need to better manage on a day-to-day basis. It is primarily provided by various software and services. Chronic disease management assists in reducing health care costs and improving the quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated care.

The increasing geriatric populace is expected to boost the chronic disease management market. The lack of accessibility is expected to restraint the chronic disease management market. The surge in novel technological advancements is expected to create an opportunity for the chronic disease management market. The lack of accessibility is expected to pose a challenge for the chronic disease management market.

The chronic disease management market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the chronic disease management market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.


Chronic Disease Management Market Scope and Market Size

The chronic disease management market is segmented on the basis of the type, solution type, service type, disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to surge in novel technological advancement. 
  • On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to rising strategic initiatives by key players.
  • On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to increasing prevalence of chronic diseases. 
  • On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to increased reimbursement policies. 
  • On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rise in awareness regarding the healthcare management service.

Middle East and Africa Chronic Disease Management Market Country Level Analysis

Middle East and Africa chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease indication and end user as referenced above.

The countries covered in the Middle East and Africa chronic disease management market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt and rest of Middle East and Africa.

Saudi Arabia is expected to dominate the Middle East and Africa chronic disease management market due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to enhance the Awareness for Chronic Disease Management is Boosting the Chronic Disease Management Market

The chronic disease management market also provides you with detailed market analysis for every country growth in chronic disease management market. Additionally, it provides the detail information regarding the chronic disease management market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Disease Management Market Share Analysis

The chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa chronic disease management market.

The major companies dealing in the Middle East and Africa chronic disease management market report are Koninklijke Philips N.V., Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, Health Catalyst, ExlServings Holdings, Inc., ScienceSoft USA Corporation, Infosys Limited, IBM Corporation among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.

For instance,

  • In April 2021, IBM Corporation launches advanced storage solutions designed to simplify data accessibility and availability across hybrid clouds. This new solution launch by parent organization IBM Corporation has enhanced the company’s overall revenue for market.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company footprints in the chronic disease management market which also provides the benefit for organization’s profit growth.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET END USER COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS

5.1 REGULATION IN THE UNITED STATES:

5.2 GOVERNING REGULATIONS:

5.3 CPT CODES:

5.4 PRACTITIONER ELIGIBILITY:

5.5 PATIENT ELIGIBILITY:

5.6 REQUIREMENTS:

5.7 REGULATIONS IN EUROPE:

5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:

5.9 DATA PRIVACY PROTECTION IN EUROPE:

5.1 REGULATIONS IN INDIA:

5.11 RELEVANT ACTS FOR THIS FRAMEWORK:

5.12 DATA PRIVACY PROTECTION IN INDIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

6.1.2 GROWING GERIATRIC POPULATION

6.1.3 RISING PER CAPITA INCOME

6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION

6.2 RESTRAINTS

6.2.1 HIGH COST OF SERVICES

6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS

6.3 OPPORTUNITIES

6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 INCREASED REIMBURSEMENT POLICIES

6.3.4 RISING DISEASE MANAGEMENT PROGRAMS

6.4 CHALLENGE

6.4.1 LACK OF ACCESSIBILITY

7 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

7.4 CONCLUSION

8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

8.1 OVERVIEW

8.2 SOLUTION

8.3 SERVICES

9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE

9.1 OVERVIEW

9.2 ON PREMISE SOLUTION

9.3 WEB BASED SOLUTION

9.4 CLOUD BASED SOLUTION

10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE

10.1 OVERVIEW

10.2 IMPLEMENTATION SERVICES

10.3 CONSULTING SERVICES

10.4 EDUCATION SERVICES

10.5 OTHERS

11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION

11.1 OVERVIEW

11.2 CARDIOVASCULAR DISEASES (CVD)

11.3 DIABETES

11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)

11.5 ASTHMA

11.6 ARTHRITIS

11.7 CANCER

11.8 OTHERS

12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

12.1 OVERVIEW

12.2 HEALTHCARE PROVIDERS

12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY

12.2.2 DIAGNOSTIC & IMAGING CENTERS

12.2.3 AMBULATORY CARE CENTERS

12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES

12.2.5 OTHERS

12.3 HEALTHCARE PAYERS

12.3.1 PUBLIC PAYERS

12.3.2 PRIVATE PAYERS

12.4 OTHERS

13 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION

13.1 MIDDLE EAST AND AFRICA

13.1.1 SOUTH AFRICA

13.1.2 SAUDI ARABIA

13.1.3 U.A.E.

13.1.4 ISRAEL

13.1.5 EGYPT

13.1.6 REST OF MIDDLE EAST & AFRICA

14 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 IBM CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 SERVICE PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 KONINKLIJKE PHILIPS N.V.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 COGNIZANT

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 ALLSCRIPTS HEALTHCARE, LLC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 SOLUTION PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 ALTRUISTA HEALTH

16.5.1 COMPANY SNAPSHOT

16.5.2 SOLUTION PORTFOLIO

16.5.3 RECENT DEVELOPMENTS

16.6 CASENET, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT & SERVICE PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 CEDAR GATE TECHNOLOGIES

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 CLIEXA, INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 SOLUTION PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 EPIC SYSTEMS CORPORATION

16.9.1 COMPANY SNAPSHOT

16.9.2 SERVICE PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 EXLSERVICE HOLDINGS, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 SERVICE PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 HEALTH CATALYST

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 HINDUJA MIDDLE EAST AND AFRICA SOLUTIONS LTD.

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 INFOSYS LIMITED

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 SOLUTION PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 MEDECISION

16.14.1 COMPANY SNAPSHOT

16.14.2 SOLUTION PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 MINES & ASSOCIATES, INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 NXGN MANAGEMENT, LLC

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 PEGASYSTEMS INC.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SCIENCESOFT USA CORPORATION

16.18.1 COMPANY SNAPSHOT

16.18.2 INDUSTRY PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 TCS HEALTHCARE TECHNOLOGIES

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 VIVIFY HEALTH, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 SOLUTION PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 WELLSKY

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

16.22 ZEOMEGA

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.

TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS

TABLE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 39 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 SOUTH AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 41 SOUTH AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 42 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 43 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 SOUTH AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 SOUTH AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 SAUDI ARABIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 48 SAUDI ARABIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 49 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 50 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 SAUDI ARABIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 SAUDI ARABIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 U.A.E. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 55 U.A.E. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 57 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 U.A.E. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 U.A.E. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 ISRAEL SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 62 ISRAEL SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 63 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 64 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 ISRAEL HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 ISRAEL HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 67 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 EGYPT SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 69 EGYPT SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 70 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 71 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 72 EGYPT HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 EGYPT HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 74 REST OF MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 15 PREVALENCE OF CHRONIC DISEASES

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)

FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)

FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)

FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)

FIGURE 20 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020

FIGURE 21 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 23 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020

FIGURE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)

FIGURE 27 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020

FIGURE 29 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)

FIGURE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020

FIGURE 33 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)

FIGURE 34 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020

FIGURE 37 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 38 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)

FIGURE 41 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)

FIGURE 42 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)

FIGURE 45 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)

View Infographics

FIGURE 1 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 15 PREVALENCE OF CHRONIC DISEASES

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)

FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)

FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)

FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)

FIGURE 20 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020

FIGURE 21 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 23 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020

FIGURE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)

FIGURE 27 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020

FIGURE 29 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)

FIGURE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020

FIGURE 33 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)

FIGURE 34 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020

FIGURE 37 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 38 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)

FIGURE 41 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)

FIGURE 42 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)

FIGURE 45 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19